Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, ...

Indian pharmaceutical company Intas Pharmaceuticals signed a deal to acquire Udenyca, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications. Accord ...

Udenyca will be sold in the US by Accord BioPharma, the specialty division of Intas Pharma. iStock Co buys Udenyca from US’ Coherus for Rs 4,784 cr to boost presence in oncology market India, get ...

Acamprosate is used to treat alcohol dependence along with other rehabilitation therapy such as counseling and social support in people who have the intention of avoiding alcohol consumption.

Ahmedabad based Intas Pharma which is a closely held company buys Tava's European assets for USD 764 million in an all cash deal. CNBC-TV18's Nisha Poddar spoke with Binish Chudgar, MD of Intas ...

Previously, from 2014 to 2020, Mr. Roy was Vice President, Business Development and Sales for Intas Pharmaceuticals Ltd., a major pharmaceutical company with a strong presence in over 85 countries.

Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research ...

Intas Pharma becomes most valuable privately held pharma company A PE deal values Intas at Rs 23,000 crore or USD 3.5 billion, making it the most valued pharma privately held company in India.

Company Description Intas Pharmaceuticals is a leading multinational pharmaceutical organization with a strong presence in various countries and top-ranking therapeutic segments like CNS, Cardio, ...

Learn about Intas Pharmaceuticals in Dehradun, Uttarakhand.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...